Renin-angiotensin-system (RAS)-acting agents, _欧盟人用和兽用药品推荐表

Renin-angiotensin-system (RAS)-acting agents,

推荐名称

Renin-angiotensin-system (RAS)-acting agents,

通用名称

captopril, imidapril, zofenopril, candesartan, delapril, telmisartan, aliskiren, moexipril, enalapril, valsartan, fosinopril, irbesartan, perindopril, quinapril, ramipril, eprosartan, olmesartan, trandolapril, losartan, azilsartan, lisinopril, spirapril, benazepril, cilazapril

授权状态

European Commission final decision

安全级别

no

参考号

分类

Human

首发日期

2013/5/17 14:00:00

欧盟推荐日期

2014/9/4 2:00:00

推荐来源

Article 31 referrals

关联名称

Tolucombi , Telmisartan Teva , Telmisartan Teva Pharma , Tolura , Onduarp , Twynsta , Actelsar HCT , Kinzalkomb , MicardisPlus , PritorPlus , Copalia HCT , Dafiro HCT , Exforge HCT , Rasilamlo , Rasilez , Rasilez HCT , Rasitrio , Edarbi , Ipreziv , Aprovel , Ifirmasta (previously Irbesartan Krka) , Irbesartan Teva , Irbesartan Zentiva (previously Irbesartan Winthrop) , Karvea , Sabervel , CoAprovel , Ifirmacombi , Irbesartan/Hydrochlorothiazide Teva , Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) , Karvezide , Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG) , Micardis , Pritor , Telmisartan Actavis

决定模型

PRAC-CHMP-EC

授权模式

Centrally and nationally authorised products (mixed)

审查监管建议

Risk minimisation measures

程序开始日期

2013/5/16 0:00:00

审查监管推荐日期

2014/4/10 2:00:00

CHMP意见/CMDh日期

2014/5/22 2:00:00